New Board Chair Announcement

June 10, 2016

Brief Biographies

Edward A. “Ned” Montgomery, Jr. was first elected to the PCMS Board in 2004, and, in 2008, he was elected Vice-Chair. He has also served PCMS as Chair of its Nominating and Development Committees and as Chair of its successful 25th Anniversary Endowment and Reserve Fund Campaign. He also serves the field of classical music as Vice-Chair of the Curtis Institute of Music. He is a Trustee of the Isabel Rockefeller Trust and Albert M. Greenfield Foundation and has been Chair of the boards of the Philadelphia Chamber of Commerce, Academy of Natural Sciences, and Trinity College, and of the Advisory Board of the Royal Oak Foundation. He is a Trustee Emeritus of The Philadelphia Orchestra Association and has served on the boards of United Way of Greater Philadelphia and Southern New Jersey, the Philadelphia Area Center for History of Science, and on the advisory board of Teach for America Greater Philadelphia, Camden. He is a retired director of Fisher Scientifics International, Mellon Bank Corporation, Pullman Corporation, and Wheelabrator Technologies, Inc. For thirty years, Mr. Montgomery worked for Mellon Bank in the U.S. and London. Before retiring in 1989, he was Vice Chairman of Mellon Bank Corporation and Chairman and Chief Executive Officer of Mellon Bank (East). He graduated from Deerfield Academy, received B.A. and L.L.D. degrees from Trinity College, and attended Harvard Business School.Roger Berlin, M.D. is an Advisor and Principal of the New England Consulting Group and an expert in global biopharmaceutical development. His career in the healthcare industry includes his leadership role as CEO and Director of Arno Therapeutics, a biopharmaceutical company that develops innovative products for cancer treatment.  His has collaborated with commercial and governmental entities, including the FDA and the European Medicines Evaluation Authority. Prior to his tenure at Arno, he was President of Global R&D at Wyeth Consumer Healthcare, where he also served on the divisional senior leadership team and the Consumer Health Products Association scientific leadership group. Dr. Berlin has also held senior leadership roles at Merck, including head of global clinical research operations, where he oversaw a 225-member staff conducting clinical trials in therapeutic areas worldwide.  He has served on the boards of rTerra (a renewable energy company), Arno Therapeutics, the advisory board of Vigilon, the Life and Healthcare Advisory board of JRG Ventures, and the clinical advisory board of Alevium. He has published extensively and has served as a reviewer for numerous journals and on the national research committee of the American Gastroenterological Association. Dr. Berlin holds a B.S. degree from Queens College, CUNY, and an M.D. from Cornell-Weill Medical College, and he completed the Advanced Management Program of the Harvard Business School. He was a Senior Fellow in the School of Population Health at Thomas Jefferson School of Medicine.

George Chressanthis, an avid amateur pianist, served as the Senior Director for Commercial Strategic Analysis at AstraZeneca Pharmaceuticals and in positions with Wyeth-Ayerst Laboratories, IMS Health, and ZS Associates. He has been a Professor of Healthcare Management and Marketing and the Director of the Center for Healthcare Research and Management in the Fox School of Business at Temple University as well as a professor in the Department of Clinical Sciences at Temple University School of Medicine. His academic research, writings, and presentations focus on the strategic, commercial, and public policy issues affecting the pharmaceutical industry. His teaching has focused on marketing and healthcare management. Prior to his pharmaceutical career, he was a tenured Professor of Economics and Associate Professor of Political Science at Mississippi State University. He has held other faculty positions and appointments at Texas Tech University, Saginaw Valley State College, SUNY-Albany, and the University of Michigan. His journal publications cover research areas in economics, political science, library science, criminology, and other disciplines. He holds a Ph.D. and M.S. in Economics from Purdue University and a B.A. in Economics from Indiana University of Pennsylvania.

Andrew R. Quint, M.D., is a retired endocrinologist who writes for Fanfare magazine and other music journals. He also serves on the board of the Musical Fund Society of Philadelphia. Dr. Quint played trombone and arranged music actively throughout his childhood, and he continued studying music at the Oberlin College and Conservatory of Music. He completed his degree with a major in biology and went on to study medicine at George Washington University. Later in life, he entered and won a recording-review contest conducted by Stereophile, and he has written for The Absolute Sound, Fanfare, Philadelphia Music Makers, and other publications. He maintains a passion for technology, including new high-resolution video formats, Blu-ray and HD DVD and is an avid record collector.